Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed May 3, 2017 · 10-Q · 33 days after period end · 0001615219-17-000032
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $242.55K | $0.00 | — |
| Net Income | -$8.27M | -$9.59M | -$6.02M |
| EPS Diluted | -$0.49 | -$0.61 | -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 3, 2017 · 33 d after period end
